{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:49:07Z","timestamp":1781333347166,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Irritable bowel syndrome (IBS) and gastrointestinal (GI) dysmotility disorders have a similar clinical picture, although dysmotility disorders require the attention of a specialist. Patients with primary Sj\u00f6gren's syndrome (pSS) have also been described to suffer from IBS-like symptoms. No objective marker is available to distinguish between the patients. A visual analogue scale has been developed for IBS patients (VAS-IBS) to measure treatment response of GI symptoms and well-being in patients with IBS. The aim of the present study was to examine if VAS-IBS could be used to compare the degree of GI complaints in different patient populations, to get an objective marker to differentiate between the patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The VAS-IBS consists of 7 VAS scales, namely, abdominal pain, diarrhoea, constipation, bloating and flatulence, vomiting and nausea, psychological well-being and the intestinal symptoms' influence on daily life. Consecutive female patients suffering from IBS, dysmotility disorders and pSS were asked to complete the VAS-IBS questionnaire when visiting the out-patient clinics. In addition, a control population consisting of healthy female volunteers was included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Healthy volunteers had almost no GI symptoms, whereas all 3 patient groups expressed symptoms. There was no statistical significant difference between IBS and dysmotility in any of the scales besides vomiting and nausea (p = 0.044). Except for constipation, patients with pSS had less severe symptoms than the others.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The VAS-IBS questionnaire could be used to assess the level of GI symptoms. However, VAS scores do not help the clinicians to differentiate between IBS and other dysmotility disturbances.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-11-122","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T19:15:36Z","timestamp":1325186136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS)"],"prefix":"10.1186","volume":"11","author":[{"given":"Mariette","family":"Bengtsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"662_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterolog. 2006, 130: 1480-91. 10.1053\/j.gastro.2005.11.061.","journal-title":"Gastroenterolog"},{"key":"662_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-230X-7-16","volume":"7","author":"M Bengtsson","year":"2007","unstructured":"Bengtsson M, Ohlsson B, Ulander K: Development and psychometric testing of the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterology. 2007, 7: 16-10.1186\/1471-230X-7-16.","journal-title":"BMC Gastroenterology"},{"key":"662_CR3","first-page":"1","volume":"23","author":"B Ohlsson","year":"2009","unstructured":"Ohlsson B, Scheja A, Janciauskiene S, Mandl T: Functional bowel symptoms and GnRH antibodies: common findings in patients with primary Sj\u00f6gren's syndrome but not in systemic sclerosis. Scand J Rheumatol. 2009, 23: 1-2.","journal-title":"Scand J Rheumatol"},{"key":"662_CR4","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3899\/jrheum.100280","volume":"37","author":"O Hammar","year":"2010","unstructured":"Hammar O, Ohlsson B, Mandl T: Impaired gastric emptying in patients with Sj\u00f6gren's syndrome. Journal of Rheumatology. 2010, 37: 2313-8. 10.3899\/jrheum.100280.","journal-title":"Journal of Rheumatology"},{"issue":"Suppl","key":"662_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1046\/j.1440-1746.17.s1.7.x","volume":"17","author":"D Wingate","year":"2002","unstructured":"Wingate D, Hongo M, Kellow J, Lindberg G, Smout A: Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol. 2002, 17 (Suppl): S1-14.","journal-title":"J Gastroenterol Hepatol"},{"key":"662_CR6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/gut.2004.043968","volume":"53","author":"R De Giorgio","year":"2004","unstructured":"De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V: Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut. 2004, 53: 1549-52. 10.1136\/gut.2004.043968.","journal-title":"Gut"},{"key":"662_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cgh.2008.03.009","volume":"6","author":"M Iwarzon","year":"2008","unstructured":"Iwarzon M, Gardulf A, Lindberg G: Health care use in patients with chronic intestinal dysmotility before and after introducing a specialized day-care unit. Clin Gastroent Hepatol. 2008, 6: 893-8. 10.1016\/j.cgh.2008.03.009.","journal-title":"Clin Gastroent Hepatol"},{"key":"662_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/00365520902839642","volume":"44","author":"G Lindberg","year":"2009","unstructured":"Lindberg G, Iwarzon M, T\u00f6rnblom H: Clinical features and long-term survival in chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol. 2009, 44: 692-9. 10.1080\/00365520902839642.","journal-title":"Scand J Gastroenterol"},{"key":"662_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.gastro.2006.10.036","volume":"132","author":"B Ohlsson","year":"2007","unstructured":"Ohlsson B, Ver\u00e9ss B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A: Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies. Gastroenterology. 2007, 132: 45-51. 10.1053\/j.gastro.2006.10.036.","journal-title":"Gastroenterology"},{"key":"662_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-230X-10-48","volume":"10","author":"B Ohlsson","year":"2010","unstructured":"Ohlsson B, Veress B, Ekblad E, Montgomery A, Janciauskiene S: Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. BMC Gastroenterology. 2010, 10: 48-10.1186\/1471-230X-10-48.","journal-title":"BMC Gastroenterology"},{"issue":"11","key":"662_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1365-2982.2011.01744.x","volume":"23","author":"B Ohlsson","year":"2011","unstructured":"Ohlsson B, Sj\u00f6berg K, Alm R, Fredriksson GN: Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum. Neurogastroenterol & Motil. 2011, 23 (11): 1000-6, e459. 10.1111\/j.1365-2982.2011.01744.x.","journal-title":"Neurogastroenterol & Motil"},{"key":"662_CR12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3109\/00365528708991965","volume":"22","author":"M Hanson","year":"1987","unstructured":"Hanson M, Lilja B: Gastric emptying in smokers. Scand J Gastroenterol. 1987, 22: 1102-4. 10.3109\/00365528708991965.","journal-title":"Scand J Gastroenterol"},{"key":"662_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/00365528809095938","volume":"23","author":"H Abrahamsson","year":"1988","unstructured":"Abrahamsson H, Antov S, Bosaeus I: Gastrointestinal and colonic segmental transit time evaluated by a single abdominal X-ray in healthy subjects and constipated patients. Scand J Gastroenterol. 1988, 23: 72-80.","journal-title":"Scand J Gastroenterol"},{"key":"662_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/gut.49.1.145","volume":"49","author":"SJ Spechler","year":"2001","unstructured":"Spechler SJ, Castell DO: Classification of oesophageal motility abnormalities. Gut. 2001, 49: 145-51. 10.1136\/gut.49.1.145.","journal-title":"Gut"},{"key":"662_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sj\u00f6gren's Syndrome: Classification criteria for Sjogren's syndrome: A revised version of the european criteria proposed by the american-european consensus group. Ann Rheum Dis. 2002, 61: 554-8. 10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"key":"662_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/rheumatology\/ken107","volume":"47","author":"T Mandl","year":"2008","unstructured":"Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson LT: Autonomic nervous symptoms in primary sjogren's syndrome. Rheumatology. 2008, 47: 914-9. 10.1093\/rheumatology\/ken107.","journal-title":"Rheumatology"},{"key":"662_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrgastro.2010.137","volume":"7","author":"S Khan","year":"2010","unstructured":"Khan S, Chang L: Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol. 2010, 7: 565-81. 10.1038\/nrgastro.2010.137.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"662_CR18","volume-title":"Neurogastroenterol Motil","author":"RF Cogliandro","year":"2011","unstructured":"Cogliandro RF, Antonucci A, De Giorgio R, Barbara G, Cremon C, Cogliandro L, Frisoni C, Pezzilli R, Morselli-Labate AM, Corinaldesi R, Stanghellini V: Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. Neurogastroenterol Motil. 2011,"},{"key":"662_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11136-009-9461-7","volume":"18","author":"J Park","year":"2009","unstructured":"Park J, Choi M, Kim YS, Choi CH, Choi SC, Hong SJ, Jeong JJ, Lee DH, Lee JS, Lee KJ, Son HJ, Sung IK: Quality of life in patients with irritable bowel syndrome in Korea. Qual Life Res. 2009, 18: 435-46. 10.1007\/s11136-009-9461-7.","journal-title":"Qual Life Res"},{"key":"662_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/003655201750153476","volume":"36","author":"M Simr\u00e9n","year":"2001","unstructured":"Simr\u00e9n M, Abrahamsson H, Svedlund J, Bj\u00f6rnsson ES: Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol. 2001, 36: 545-52.","journal-title":"Scand J Gastroenterol"},{"key":"662_CR21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0016-5085(88)80017-9","volume":"95","author":"DA Drossman","year":"1988","unstructured":"Drossman DA, McKee DC, Sandler RS, Mtchell CM, Cramer EM, Lowman BC, Burger AL: Psychological factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988, 95: 701-8.","journal-title":"Gastroenterology"},{"key":"662_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0022-3999(02)00351-3","volume":"53","author":"C Crane","year":"2002","unstructured":"Crane C, Martin M: Perceived vulnerability to illness in individuals with irritable bowel syndrome. J Psychosom Res. 2002, 53: 1115-2. 10.1016\/S0022-3999(02)00351-3.","journal-title":"J Psychosom Res"},{"key":"662_CR23","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gut.2006.117390","volume":"56","author":"SD Dorn","year":"2007","unstructured":"Dorn SD, Palsson OS, Thiwan SI, Kanazawa M, Clark WC, van Tilburg MA, Drossman DA, Scarlett Y, Levy RL, Ringel Y, Crowell MD, Olden KW, Whitehead WE: Increased colonic pain sensitivity in irritable bowel syndrome is the results of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut. 2007, 56: 1202-9. 10.1136\/gut.2006.117390.","journal-title":"Gut"},{"key":"662_CR24","first-page":"2115","volume":"90","author":"NJ Talley","year":"1995","unstructured":"Talley NJ, Boyce PM, Bronwen KO: Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995, 90: 2115-9.","journal-title":"Am J Gastroenterol"},{"key":"662_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1542-3565(04)00350-7","volume":"2","author":"CS North","year":"2004","unstructured":"North CS, Downs D, Clouse RE, Alrakawi A, Dokucu ME, Cox J, Spitznagel EL, Alpers DH: The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol. 2004, 2: 787-95. 10.1016\/S1542-3565(04)00350-7.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"662_CR26","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3748\/wjg.v13.i14.2020","volume":"13","author":"CS North","year":"2007","unstructured":"North CS, Hong BA, Alpers DH: Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol. 2007, 13: 2020-7.","journal-title":"World J Gastroenterol"},{"key":"662_CR27","first-page":"6","volume":"48","author":"C Pinto","year":"2000","unstructured":"Pinto C, Lele MV, Joglekar AS, Panwar VS, Dhavale HS: Stressful life-events, anxiety, depression and coping in patients of irritable bowel syndrome. JAPI. 2000, 48: 6-","journal-title":"JAPI"},{"key":"662_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2007.11.011","volume":"134","author":"Y Ringel","year":"2008","unstructured":"Ringel Y, Drossman DA, Leserman JL, Suyenobu BY, Wilber K, Lin W, Whitehead WE, Naliboff BD, Berman S, Mayer EA: Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology. 2008, 134: 396-404. 10.1053\/j.gastro.2007.11.011.","journal-title":"Gastroenterology"},{"key":"662_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/gut.2008.175000","volume":"59","author":"S Elsenbruch","year":"2010","unstructured":"Elsenbruch S, Rosenberger C, Enck P, Forsting M, Schedlowski M, Gizewski ER: Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut. 2010, 59: 489-95. 10.1136\/gut.2008.175000.","journal-title":"Gut"},{"key":"662_CR30","doi-asserted-by":"publisher","first-page":"74S","DOI":"10.1016\/S0002-9343(99)00083-2","volume":"107","author":"F Creed","year":"1999","unstructured":"Creed F: The relationship between psychosocial parameters and outcome in irritable bowel syndrome. Am J Med. 1999, 107: 74S-80S.","journal-title":"Am J Med"},{"issue":"5 Suppl 3","key":"662_CR31","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1097\/01.mcg.0000156107.13247.69","volume":"39","author":"DA Drossman","year":"2005","unstructured":"Drossman DA: What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders?. J Clin Gastroenterol. 2005, 39 (5 Suppl 3): S251-6.","journal-title":"J Clin Gastroenterol"},{"key":"662_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/03009740701607638","volume":"36","author":"T Mandl","year":"2007","unstructured":"Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT: Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sj\u00f6gren's syndrome. Scand J Rheumatol. 2007, 36: 394-401. 10.1080\/03009740701607638.","journal-title":"Scand J Rheumatol"},{"key":"662_CR33","first-page":"1","volume":"10","author":"M Grover","year":"2009","unstructured":"Grover M, Drossman DA: Pain management in IBD. Inflamm Bowel Dis Monit. 2009, 10: 1-10.","journal-title":"Inflamm Bowel Dis Monit"},{"key":"662_CR34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","volume":"97","author":"YA Saito","year":"2002","unstructured":"Saito YA, Schoenfeld P, Locke GR: The epidemiology of irritable bowel syndrome in North America: a systemic review. Am J Gastroenterol. 2002, 97: 910-5. 10.1111\/j.1572-0241.2002.05608.x.","journal-title":"Am J Gastroenterol"},{"key":"662_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","volume":"17","author":"AP Hungin","year":"2003","unstructured":"Hungin AP, Whorwell PJ, Tack J, Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther. 2003, 17: 643-50. 10.1046\/j.1365-2036.2003.01456.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"662_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004, 126: 693-702. 10.1053\/j.gastro.2003.11.055.","journal-title":"Gastroenterology"},{"key":"662_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/gut.47.6.804","volume":"47","author":"RC Spiller","year":"2000","unstructured":"Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000, 47: 804-11. 10.1136\/gut.47.6.804.","journal-title":"Gut"},{"key":"662_CR38","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","volume":"93","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Spiller RC: Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003, 93: 1578-83.","journal-title":"Am J Gastroenterol"},{"key":"662_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1590-8658(00)80021-3","volume":"32","author":"MA O'Sullivan","year":"2000","unstructured":"O'Sullivan MA, O'Morain CA: Bacterial supplementation in the irritable bowel syndrome. A randomized double-blind placebo-controlled crossover study. Dig Liver Dis. 2000, 32: 294-301. 10.1016\/S1590-8658(00)80021-3.","journal-title":"Dig Liver Dis"},{"key":"662_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/01.SGA.0000267924.24180.1a","volume":"30","author":"M Bengtsson","year":"2007","unstructured":"Bengtsson M, Ohlsson B, Ulander K: Women with irritable bowle syndrome and their perception of a good quality of life. Gastroenterology Nursing. 2007, 30: 74-82. 10.1097\/01.SGA.0000267924.24180.1a.","journal-title":"Gastroenterology Nursing"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-11-122\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:54:09Z","timestamp":1630518849000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-11-122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["662"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-11-122","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]},"assertion":[{"value":"26 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"122"}}